2024 Q3 Form 10-Q Financial Statement

#000149315224030485 Filed on August 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q3
Revenue $1.846M $1.659M
YoY Change 5.49% -65.35%
Cost Of Revenue $944.0K $803.0K
YoY Change 7.76% -67.46%
Gross Profit $902.0K $856.0K
YoY Change 3.2% -63.11%
Gross Profit Margin 48.86% 51.6%
Selling, General & Admin $915.0K $985.0K
YoY Change -22.06% -288.46%
% of Gross Profit 101.44% 115.07%
Research & Development $141.0K $186.0K
YoY Change -21.67% -165.53%
% of Gross Profit 15.63% 21.73%
Depreciation & Amortization $2.000K
YoY Change -95.65%
% of Gross Profit 0.23%
Operating Expenses $1.056M $1.171M
YoY Change -32.65% -245.2%
Operating Profit -$154.0K -$315.0K
YoY Change -77.81% -110.07%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $8.000K $7.000K
YoY Change -46.67% -46.15%
Pretax Income -$146.0K -$5.248M
YoY Change -78.5% -40.01%
Income Tax -$379.0K
% Of Pretax Income
Net Earnings -$146.0K -$4.869M
YoY Change -78.5% -45.56%
Net Earnings / Revenue -7.91% -293.49%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 -$0.02
COMMON SHARES
Basic Shares Outstanding 226.0M shares 224.4M shares 213.6M shares
Diluted Shares Outstanding 225.0M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.053M
YoY Change -65.25%
Cash & Equivalents $1.105M $1.100M
Short-Term Investments
Other Short-Term Assets $561.0K
YoY Change 12.2%
Inventory
Prepaid Expenses $381.0K
Receivables $865.0K $834.0K
Other Receivables $0.00
Total Short-Term Assets $2.418M $2.448M
YoY Change -9.17% -40.9%
LONG-TERM ASSETS
Property, Plant & Equipment $36.00K $30.00K
YoY Change 50.0%
Goodwill $1.356M $1.356M
YoY Change 0.0% -3.14%
Intangibles $0.00
YoY Change -100.0%
Long-Term Investments
YoY Change
Other Assets $150.0K
YoY Change -54.55%
Total Long-Term Assets $1.407M $1.536M
YoY Change -78.4% -76.82%
TOTAL ASSETS
Total Short-Term Assets $2.418M $2.448M
Total Long-Term Assets $1.407M $1.536M
Total Assets $3.825M $3.984M
YoY Change -58.32% -63.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $613.0K
YoY Change -22.01%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $50.00K
YoY Change 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $997.0K $954.0K
YoY Change -11.06% -17.83%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $997.0K $954.0K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $997.0K $954.0K
YoY Change -25.15% -30.47%
SHAREHOLDERS EQUITY
Retained Earnings -$19.58M -$18.94M
YoY Change 39.19% 58.71%
Common Stock $226.0K $214.0K
YoY Change 6.1% 43.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.828M $3.030M
YoY Change
Total Liabilities & Shareholders Equity $3.825M $3.984M
YoY Change -58.32% -63.0%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q3
OPERATING ACTIVITIES
Net Income -$146.0K -$4.869M
YoY Change -78.5% -45.56%
Depreciation, Depletion And Amortization $2.000K
YoY Change -95.65%
Cash From Operating Activities -$385.0K
YoY Change -121.4%
INVESTING ACTIVITIES
Capital Expenditures $8.000K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$8.000K
YoY Change -100.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -385.0K
Cash From Investing Activities -8.000K
Cash From Financing Activities 0.000
Net Change In Cash -393.0K
YoY Change -108.06%
FREE CASH FLOW
Cash From Operating Activities -$385.0K
Capital Expenditures $8.000K
Free Cash Flow -$393.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001022505
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-0837077
dei Entity Address Address Line1
EntityAddressAddressLine1
146 Main Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Worcester
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01608
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5509000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
390000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
483000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
1056000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-154000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-146000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-146000 usd
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 405
dei Local Phone Number
LocalPhoneNumber
925-0114
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
225975331 shares
CY2024Q2 us-gaap Cash
Cash
1105000 usd
CY2023Q3 us-gaap Cash
Cash
1053000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
865000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
834000 usd
CY2024Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
180000 usd
CY2023Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
180000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
381000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
2418000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
2448000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
1356000 usd
CY2024Q2 us-gaap Deferred Costs
DeferredCosts
15000 usd
CY2023Q3 us-gaap Deferred Costs
DeferredCosts
150000 usd
CY2024Q2 us-gaap Assets
Assets
3825000 usd
CY2023Q3 us-gaap Assets
Assets
3984000 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2024Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 SDCH Stock Issued During Period Value For Warrants
StockIssuedDuringPeriodValueForWarrants
usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
SDCH Stock Based Compensation Included In Accounts Payable And Accrued Liabilities
StockBasedCompensationIncludedInAccountsPayableAndAccruedLiabilities
usd
SDCH Purchase Of Restricted Stock Units Sold By Employees To Pay For Taxes Due On Vested Rsus
PurchaseOfRestrictedStockUnitsSoldByEmployeesToPayForTaxesDueOnVestedRsus
usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
dei Document Type
DocumentType
10-Q
dei Entity File Number
EntityFileNumber
000-28745
dei Entity Registrant Name
EntityRegistrantName
SideChannel, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei City Area Code
CityAreaCode
(508)
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q2 us-gaap Cash
Cash
1105000 usd
CY2023Q3 us-gaap Cash
Cash
1053000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
865000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
834000 usd
CY2024Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
180000 usd
CY2023Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
180000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
268000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
381000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
2418000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
2448000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
1356000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
1356000 usd
CY2024Q2 us-gaap Deferred Costs
DeferredCosts
15000 usd
CY2023Q3 us-gaap Deferred Costs
DeferredCosts
150000 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
350000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
613000 usd
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
647000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
50000 usd
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
11000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
997000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
997000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
954000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
225975331 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
225975331 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
213854781 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213854781 shares
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
350000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
613000 usd
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
647000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
50000 usd
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
11000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
997000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
954000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
997000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
954000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
225975331 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
225975331 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
213854781 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213854781 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
226000 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
214000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22186000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21755000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19584000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18939000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2828000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3030000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3825000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3984000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1846000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1750000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4913000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
944000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
876000 usd
us-gaap Cost Of Revenue
CostOfRevenue
2894000 usd
us-gaap Cost Of Revenue
CostOfRevenue
2437000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
902000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
874000 usd
us-gaap Gross Profit
GrossProfit
2615000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
834000 usd
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
137000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
340000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
141000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
180000 usd
CY2023Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
214000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
214000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1568000 usd
us-gaap Operating Expenses
OperatingExpenses
3288000 usd
us-gaap Operating Expenses
OperatingExpenses
4635000 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
226000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22186000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19584000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18939000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3030000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3825000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3984000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1846000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1750000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
944000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
876000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
874000 usd
us-gaap Gross Profit
GrossProfit
2476000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
778000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
834000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2336000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2854000 usd
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
137000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
340000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
562000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1084000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
141000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
180000 usd
CY2023Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
214000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
214000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1568000 usd
us-gaap Operating Expenses
OperatingExpenses
3288000 usd
us-gaap Operating Expenses
OperatingExpenses
4635000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-694000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-673000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2159000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
29000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-644000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2137000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-679000 usd
us-gaap Net Income Loss
NetIncomeLoss
-645000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2137000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-694000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-673000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2159000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
29000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-679000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-644000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2137000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-679000 usd
us-gaap Net Income Loss
NetIncomeLoss
-645000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
225032119 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
225032119 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189435933 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189435933 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220770171 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
220770171 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
162367526 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
162367526 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3030000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
81000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-246000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2873000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
12000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
133000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-253000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2765000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
209000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-146000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2828000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9396000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
18000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
118000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-602000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8930000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
13000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
117000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-856000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8204000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8204000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
16000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
90000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
225032119 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
225032119 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189435933 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189435933 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220770171 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
220770171 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
162367526 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
162367526 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3030000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
81000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-246000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2873000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
12000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
133000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2765000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
209000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-146000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2828000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
18000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
118000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-602000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8930000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
13000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
117000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-856000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8204000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8204000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
16000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
90000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
90000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-679000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
214000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7845000 usd
us-gaap Net Income Loss
NetIncomeLoss
-645000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2137000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
144000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
135000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
443000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
351000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
214000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
262000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-113000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-247000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
50000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-50000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
52000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1584000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
90000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-679000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
214000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7845000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7845000 usd
us-gaap Net Income Loss
NetIncomeLoss
-645000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2137000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
144000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
135000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
443000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
351000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
214000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
262000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-113000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-158000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-274000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-247000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
367000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
228000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
117000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1560000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
50000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-50000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
52000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1053000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3030000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1446000 usd
SDCH Stock Based Compensation Included In Accounts Payable And Accrued Liabilities
StockBasedCompensationIncludedInAccountsPayableAndAccruedLiabilities
21000 usd
us-gaap Stock Issued1
StockIssued1
20000 usd
us-gaap Stock Issued1
StockIssued1
31000 usd
SDCH Purchase Of Restricted Stock Units Sold By Employees To Pay For Taxes Due On Vested Rsus
PurchaseOfRestrictedStockUnitsSoldByEmployeesToPayForTaxesDueOnVestedRsus
118000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1053000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3030000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1105000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1446000 usd
us-gaap Stock Issued1
StockIssued1
20000 usd
us-gaap Stock Issued1
StockIssued1
31000 usd
SDCH Purchase Of Restricted Stock Units Sold By Employees To Pay For Taxes Due On Vested Rsus
PurchaseOfRestrictedStockUnitsSoldByEmployeesToPayForTaxesDueOnVestedRsus
118000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zoOoMGdXgh44" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_zHq1JBJeuRb6">Reclassifications</span></span></i></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Certain prior year amounts have been reclassified to be comparable with the current year’s presentation or adjusted due to rounding and have had no impact on net income or stockholders’ equity.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p>
us-gaap Net Income Loss
NetIncomeLoss
-645000 usd
us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
587000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
117000 usd
SDCH Cash Increase Decrease
CashIncreaseDecrease
52000 usd
SDCH Cash Used For Investing And Financing Activities
CashUsedForInvestingAndFinancingActivities
-65000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zoOoMGdXgh44" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_zHq1JBJeuRb6">Reclassifications</span></span></i></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Certain prior year amounts have been reclassified to be comparable with the current year’s presentation or adjusted due to rounding and have had no impact on net income or stockholders’ equity.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p>
us-gaap Net Income Loss
NetIncomeLoss
-645000 usd
us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
587000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
117000 usd
SDCH Cash Increase Decrease
CashIncreaseDecrease
52000 usd
SDCH Cash Used For Investing And Financing Activities
CashUsedForInvestingAndFinancingActivities
-65000 usd
SDCH New Accounting Pronouncements Not Yet Adopted
NewAccountingPronouncementsNotYetAdopted
<p id="xdx_84D_ecustom--NewAccountingPronouncementsNotYetAdopted_z5ZlElzAqlD1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86F_zL9P0nPuOuA2">Recently Issued Accounting Standards Not Yet Adopted</span></span></i> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which provides guidance to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the guidance enhances interim disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss, provides new segment disclosure requirements for entities with a single reportable segment and contains other disclosure requirements. The purpose of the guidance is to enable investors to better understand an entity’s overall performance and assess potential future cash flows. The guidance is effective for fiscal years beginning December 15, 2023, and interim periods within fiscal years beginning December 15, 2024. For us, annual reporting requirements will be effective for our fiscal year 2025 beginning on October 1, 2024, and interim reporting requirements will be effective beginning with our fourth quarter of fiscal year 2025. Early adoption is permitted. </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which updates income tax disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation table and disaggregation of income taxes paid, net of refunds, by jurisdiction. All entities are required to apply the guidance prospectively, with the option to apply it retrospectively. The guidance is effective for fiscal years beginning after December 15, 2024, which for us is our fiscal year 2026 beginning on October 1, 2025. Early adoption is permitted. </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The Company does not believe that the above recently issued, but not yet effective accounting standards, when adopted, will have a material effect on the accompanying consolidated financial statements.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">In March 2024, the Securities and Exchange Commission issued a rule which will require companies to make certain climate-related disclosures in periodic filings. The rule includes certain disclosures in the footnotes of the financial statements:</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; margin: 0pt 0pt 0pt 0.5in">● capitalized costs, expenditures expensed, and losses incurred as a result of severe weather events and other natural conditions, such as hurricanes, tornadoes, flooding, drought, wildfires, extreme temperatures, and sea level rise;</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">● capitalized costs, expenditures expensed, and losses related to carbon offsets and renewable energy credits or certificates if they are used as a material component of a registrant’s plans to achieve its disclosed climate-related targets or goals; and</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">● whether estimates and assumptions used to produce the financial statements were materially impacted by risks and uncertainties associated with severe weather events and other natural conditions or any disclosed climate-related targets or transition plans.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">The footnote disclosures are effective for annual filings for the year ended September 30, 2026. The Company is currently evaluating the impact of the adoption of the rule.</p>
CY2021Q4 us-gaap Area Of Land
AreaOfLand
500 sqft
CY2021Q4 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
option to renew annually for three twelve-month periods through December 2025. The annual renewal date is January 1st
CY2021Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
967 usd
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
647000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000 usd
SDCH New Accounting Pronouncements Not Yet Adopted
NewAccountingPronouncementsNotYetAdopted
<p id="xdx_84D_ecustom--NewAccountingPronouncementsNotYetAdopted_z5ZlElzAqlD1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86F_zL9P0nPuOuA2">Recently Issued Accounting Standards Not Yet Adopted</span></span></i> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which provides guidance to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the guidance enhances interim disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss, provides new segment disclosure requirements for entities with a single reportable segment and contains other disclosure requirements. The purpose of the guidance is to enable investors to better understand an entity’s overall performance and assess potential future cash flows. The guidance is effective for fiscal years beginning December 15, 2023, and interim periods within fiscal years beginning December 15, 2024. For us, annual reporting requirements will be effective for our fiscal year 2025 beginning on October 1, 2024, and interim reporting requirements will be effective beginning with our fourth quarter of fiscal year 2025. Early adoption is permitted. </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which updates income tax disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation table and disaggregation of income taxes paid, net of refunds, by jurisdiction. All entities are required to apply the guidance prospectively, with the option to apply it retrospectively. The guidance is effective for fiscal years beginning after December 15, 2024, which for us is our fiscal year 2026 beginning on October 1, 2025. Early adoption is permitted. </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The Company does not believe that the above recently issued, but not yet effective accounting standards, when adopted, will have a material effect on the accompanying consolidated financial statements.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">In March 2024, the Securities and Exchange Commission issued a rule which will require companies to make certain climate-related disclosures in periodic filings. The rule includes certain disclosures in the footnotes of the financial statements:</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; margin: 0pt 0pt 0pt 0.5in">● capitalized costs, expenditures expensed, and losses incurred as a result of severe weather events and other natural conditions, such as hurricanes, tornadoes, flooding, drought, wildfires, extreme temperatures, and sea level rise;</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">● capitalized costs, expenditures expensed, and losses related to carbon offsets and renewable energy credits or certificates if they are used as a material component of a registrant’s plans to achieve its disclosed climate-related targets or goals; and</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">● whether estimates and assumptions used to produce the financial statements were materially impacted by risks and uncertainties associated with severe weather events and other natural conditions or any disclosed climate-related targets or transition plans.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">The footnote disclosures are effective for annual filings for the year ended September 30, 2026. The Company is currently evaluating the impact of the adoption of the rule.</p>
CY2021Q4 us-gaap Area Of Land
AreaOfLand
500 sqft
CY2021Q4 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
option to renew annually for three twelve-month periods through December 2025. The annual renewal date is January 1st
CY2021Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
967 usd
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
647000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000 usd
SDCH Contract With Customer Liability Revenue Deferred
ContractWithCustomerLiabilityRevenueDeferred
1100000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
733000 usd
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
647000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000 usd
SDCH Contract With Customer Liability Revenue Deferred
ContractWithCustomerLiabilityRevenueDeferred
1100000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
733000 usd
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
647000 usd
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
225975331 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213854781 shares
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
437643 shares
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
17415437 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.18
CY2023Q4 SDCH Bid Price
BidPrice
0.36
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
43200000 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5509000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4913000 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213854781 shares
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
437643 shares
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
17415437 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.18
CY2023Q4 SDCH Bid Price
BidPrice
0.36
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
43200000 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5509000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4913000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
561000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
561000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20000 usd
us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
541000 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
541000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
372000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
47000 usd
us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
325000 usd
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.05
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.10
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0436 pure
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.8297 pure
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4400000 shares
us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
541000 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
541000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
372000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
47000 usd
us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
325000 usd
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.05
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.10
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0436 pure
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.8297 pure
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4400000 shares
SDCH Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod
1100000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3300000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
1100000 shares
SDCH Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod
1100000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3300000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
1100000 shares
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001493152-24-030485-index-headers.html Edgar Link pending
0001493152-24-030485-index.html Edgar Link pending
0001493152-24-030485.txt Edgar Link pending
0001493152-24-030485-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
f10-q_001.jpg Edgar Link pending
f10-q_002.jpg Edgar Link pending
f10-q_003.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sdch-20240630.xsd Edgar Link pending
Show.js Edgar Link pending
sdch-20240630_def.xml Edgar Link unprocessable
sdch-20240630_lab.xml Edgar Link unprocessable
sdch-20240630_pre.xml Edgar Link unprocessable
sdch-20240630_cal.xml Edgar Link unprocessable